Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01704547 · ClinicalTrials.gov registry record
Breast Cup Immobilization Device II (GCC 1047)
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 25
- Enrollment target
NCT01704547 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 25 participants.
The verdict
NCT01704547 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The study is designed to assess the accuracy of patient breast reproducibly using the revised BCID. This study would provide data for target verification and quality assurance to eventually allow treatment of breast cancer patients for either a TBB or accelerated partial breast irradiation. The BCID is a low-risk device similar to immobilization devices used routinely in radiotherapy for other disease sites.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01704547
The ClinicalTrials.gov registry entry for NCT01704547 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01704547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01704547 about?
NCT01704547 is a clinical study titled "Breast Cup Immobilization Device II (GCC 1047)". The study is designed to assess the accuracy of patient breast reproducibly using the revised BCID. This study would provide data for target verification and quality assurance to eventually allow treatment of breast cancer patients for either a TBB or accelerated partial breast irradiation. The BCID...
What is the current status of trial NCT01704547?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2012-10. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT01704547?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.